A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

Robert W. Ross, Tomasz M. Beer, Susanna Jacobus, Glenn J. Bubley, Mary Ellen Taplin, Christopher W. Ryan, Jiaoti Huang, William K. Oh

Research output: Contribution to journal › Article › peer-review

109 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel'. Together they form a unique fingerprint.

Medicine & Life Sciences